Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Treasury Shares (2021 - 2023)

Pasithea Therapeutics (KTTA) has disclosed Treasury Shares for 3 consecutive years, with $266171.0 as the latest value for Q4 2023.

  • Quarterly Treasury Shares fell 91.7% to $266171.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $266171.0 through Dec 2023, down 91.7% year-over-year, with the annual reading at $266171.0 for FY2023, 91.7% down from the prior year.
  • Treasury Shares hit $266171.0 in Q4 2023 for Pasithea Therapeutics, roughly flat from $266171.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.2 million in Q4 2022 to a low of $10000.0 in Q4 2021.
  • Historically, Treasury Shares has averaged $936906.0 across 3 years, with a median of $266171.0 in 2023.
  • Biggest five-year swings in Treasury Shares: surged 31952.82% in 2022 and later tumbled 91.7% in 2023.
  • Year by year, Treasury Shares stood at $10000.0 in 2021, then soared by 31952.82% to $3.2 million in 2022, then tumbled by 91.7% to $266171.0 in 2023.
  • Business Quant data shows Treasury Shares for KTTA at $266171.0 in Q4 2023, $266171.0 in Q3 2023, and $3.2 million in Q4 2022.